Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
暂无分享,去创建一个
G. Groenewegen | J. Haanen | G. Vreugdenhil | M. Los | M. Polée | A. T. Ten Tije | C. V. van Herpen | S. Oosting | A. Bex | P. Hamberg | S. Osanto | A. V. D. van den Eertwegh | A. V. D. van der Veldt | S. Mulder | L. Pronk | Y. Abu-Ghanem | M. Aarts | F. Peters | M. Tascilar | A. V. D. van der Veldt | D. Houtsma | S. Verhaart | D. Houtsma